The waiting goes on but the campaign and the science continues amidst encouraging signs. The prestigious US publication @TIME hails Evusheld, the antibody treatment, as one of the best innovations of the year. And Dr Lennard Lee introduces us to the people who have helped him with a new report showing encouraging stats.All that and a bit of patient politics!